Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
- PMID: 29438514
- DOI: 10.1093/europace/eux373
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
Erratum in
-
Corrigendum.Europace. 2018 May 1;20(5):738. doi: 10.1093/europace/euy119. Europace. 2018. PMID: 29722802 No abstract available.
Comment in
-
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from EHRA and ESC WG on Cardiovascular Pharmacology endorsed by HRS, APHRS, and ISCP-Authors' reply.Europace. 2018 Nov 1;20(11):1873-1874. doi: 10.1093/europace/euy217. Europace. 2018. PMID: 30312392 No abstract available.
-
Comment on 'Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from EHRA'.Europace. 2018 Nov 1;20(11):1873. doi: 10.1093/europace/euy193. Europace. 2018. PMID: 30312398 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
